| pCR | Non-pCR |
---|---|---|
Number of patients | 36 | 81 |
Mean age, years | 53 (23–72) | 48 (26–79) |
Receptor status | ||
 ER+ | 17 | 66 |
 PR+ | 15 | 58 |
 HER2+ | 16 | 12 |
 TN | 10 | 9 |
1.5-T DCE-MRI | 30 | 60 |
 Scanner 1 | 17 | 40 |
 Scanner 2 | 12 | 15 |
 Scanner 3 | 1 | 5 |
3-T DCE-MRI | 6 | 21 |
 Scanner 4 | 0 | 2 |
 Scanner 5 | 3 | 10 |
 Scanner 6 | 3 | 9 |
Lesion diameter, cm | ||
 Mean | 3.9 | 4.2 |
 SD | 2.4 | 2.6 |
Stage | ||
 I | 5 | 6 |
 II | 18 | 43 |
 III | 13 | 31 |
 IV | 0 | 1 |
Enhancing mass | 29 | 69 |
Non-mass enhancement | 7 | 12 |